Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2025-12-24 @ 1:40 PM
NCT ID: NCT01365195
Eligibility Criteria: Inclusion Criteria 1. Patients scheduled to undergo small and/or large partial bowel resection via laparotomy or laparoscopy 2. Willingness and ability to sign an informed consent document 3. No allergies to anesthetic or analgesic medications 4. 18 - 80 years of age 5. American Society of Anesthesiologists (ASA) Class I - III adults of either sex Exclusion Criteria 1. Inability to comprehend the pain assessment tools 2. Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications 3. Patients with clinically-significant heart disease including arrhythmias and significant hypertension, brain aneurysms, prior history of cerebral vascular accident (CVA), or chronic renal insufficiency 4. Prior abdominal surgery 5. History of abdominal carcinomatosis 6. History of radiation enteritis; 7. Patients with history of hepatic, renal, cardiac failure, organ transplant, or diabetes 8. Patients with seizures 9. Morbid obesity (body mass index \>40) 10. Pregnant or lactating women 11. Subjects with a history of alcohol or drug abuse within the past 3 months 12. Any other conditions or use of any medication which may interfere with the conduct of the study 13. Prophylactic Nasogastric Tube (NGT) use 14. Individuals with significant manic disorders including: schizophrenia, or bipolar disorder or psychosis 15. Individuals with asthma and/or thyroid diseases
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT01365195
Study Brief:
Protocol Section: NCT01365195